Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Synthomer Q1 EBITDA grows despite 'modestly lower' volumes

(Sharecast News) - Chemicals business Synthomer said on Thursday that underlying earnings and margins had both improved year-on-year during Q1 despite "modestly lower" volumes, driven by self-help initiatives. Synthomer said its Adhesive Solutions and Health & Protection and Performance Materials divisions both delivered increased gross margins and underlying earnings, principally through a further improvement in product and geographical mix and self-help cost efficiency programmes.

However, in its Coatings & Construction Solutions unit, delayed energy orders and moderating end-market activity in the USA were only partially offset by improved construction activity in Europe. Synthomer also highlighted that "robust pricing" continued to be achieved across the group, recognising lower energy and raw materials costs in the period.

The FTSE 250-listed group also noted that its strategy of manufacturing close to customers globally "substantially mitigates" its direct exposure to recent tariff announcements, which it intends to offset through price. At the same time, Synthomer said geopolitical tensions had made end-market demand "more unpredictable", particularly in the USA, which represents around 25% of revenues. Despite this, Synthomer continues to expect further earnings progress and positive free cash flow in 2025.

Chief executive Michael Willome said: "We delivered earnings growth in Q1 2025 against difficult market trends and a strong first quarter last year, largely through our relentless focus on our customers, costs and cash. Our 'in region for region' manufacturing strategy means we are in a robust position to weather a more protectionist trade environment.

"Alongside our ongoing prioritisation of deleveraging, we continue to rigorously allocate our resources to key growth opportunities across our global business. Although our end-markets face increasing macroeconomic and geopolitical uncertainty, our strategic transformation continues to enhance our ability to convert customer demand for our products into substantially greater profitability and returns."

As of 0805 BST, Synthomer shares were down 2.19% at 80.50p.

Reporting by Iain Gilbert at Sharecast.com

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.